ArticleThe Journal of urology2013

Re: a phase 2 cancer chemoprevention biomarker trial of isoflavone g-2535 (genistein) in presurgical bladder cancer patients.

David P WoodPubMed ↗Publisher ↗

No numbers read from the abstract.